MADRID (Reuters) – Spain’s medicines agency has authorized the first round of clinical trials for the COVID-19 vaccine developed by Spanish company Hipra, Prime Minister Pedro Sanchez told reporters on Wednesday.
“Spain’s medicines and health products agency has just authorized clinical tests of the Spanish COVID vaccine on humans,” Sanchez said at a news conference in Lanzarote.
(Reporting by Inti Landauro; Editing by Nathan Allen)
